WS #16786
Lufthansa has narrowed its 2026 adjusted EBIT guidance to €1.7B-€2.0B, citing a €9.3B fuel bill outlook, reflecting the ongoing pressure on airlines from high energy costs. In contrast, Strata Medical signaled high-teens organic adjusted EBITDA growth for 2027 and authorized a $20M buyback, indicating strength in the medical device sector. AUTO1 Group and BMW also reported Q3 results, with BMW reducing its workforce in China, highlighting regional operational adjustments.
Corporate Earnings & Guidance
Lufthansa has narrowed its 2026 adjusted EBIT guidance to €1.7B-€2.0B, citing a €9.3B fuel bill outlook, reflecting the ongoing pressure on airlines from high energy costs. In contrast, Strata Medical signaled high-teens organic adjusted EBITDA growth for 2027 and authorized a $20M buyback, indicating strength in the medical device sector. AUTO1 Group and BMW also reported Q3 results, with BMW reducing its workforce in China, highlighting regional operational adjustments.